Why is Retatrutide your most popular peptide?

Retatrutide is currently the most advanced candidate in metabolic research because it targets three receptors (GLP-1, GIP, and Glucagon) simultaneously. This "triple-G" mechanism has shown in studies to produce significantly higher efficacy in weight reduction and metabolic normalization compared to single or dual agonists.

What research areas benefit most from Retatrutide?

It is primarily used in research regarding obesity management, type 2 diabetes, hepatic steatosis (fatty liver), and lipid metabolism.

How does the glucagon receptor component enhance research?

Unlike GLP-1 and GIP which mainly affect satiety and insulin, the Glucagon receptor component increases energy expenditure (burning calories) and improves lipid profiles, offering a unique "fat-burning" pathway for study.

What purity and quality standards does Retatrutide meet?

Our Retatrutide is synthesized to >99% purity, verified by HPLC and Mass Spectrometry. It is pharmaceutical-grade and suitable for high-precision laboratory experiments.

Why do researchers worldwide prefer Retatrutide over dual agonists?

Researchers prefer it for studies requiring maximum potency. The synergistic effect of the third receptor allows for lower dosages with potentially higher outcomes in test subjects.

How many dosage options are available and why?

We offer 8 variants (RT5 to RT60) to allow researchers to conduct precise dose-escalation studies, finding the exact "sweet spot" for efficacy vs. tolerance in their subjects.

Can Retatrutide be used in comparative studies with other agonists?

Yes, it is frequently used as the "superior arm" in comparative studies against Tirzepatide (Dual) and Semaglutide (Single) to demonstrate the efficacy gap.

What documentation supports publication-quality research?

We provide full Certificates of Analysis (CoA) and purity reports, making our compounds suitable for peer-reviewed citations.

Home ProductsRetatrutide

Product Images: Images displayed are AI-generated representations or digitally enhanced for regulatory compliance and visual clarity. Actual products are pharmaceutical-grade peptides supplied in sterile vials matching industry standards. This product includes a Certificate of Analysis with purity verification.

RT5

Retatrutide

For research and laboratory use only. Not for human consumption.

Triple agonist (GLP-1 + GIP + Glucagon) - Premier metabolic research compound

Pick Your Size

Select Quantity

Researcher·1 Kit

Volume pricing

Per-kit price drops as you scale

Add 1 more kit

Unlock Lab pricing at $215/kit

+$190

extra savings

Total Price

$310

Free Worldwide Shipping

No minimum order. Customs handled.

Express Delivery

7-14 Days

Ships To

190+ Countries

Customs Handled

99% Success Rate

Stealth Packaging

Cold-Chain

Lab-Grade Guarantee

If an independent HPLC assay of your lot comes back below the purity stated on our published Certificate of Analysis, we reship your order free. Verifiable, not a promise.

99.45% Purity Verified

HPLC / ESI-MS Tested

View Report

FOR RESEARCH PURPOSES ONLY. This product is strictly for laboratory and research use. Not for human consumption, medical treatment, or any clinical application. By ordering, you confirm you are a qualified researcher or represent a legitimate research institution.

Retatrutide: Key Facts

Retatrutide is a weight loss research peptide supplied by LyzeLabs as a lyophilized reference standard, strictly for laboratory research use. It is available in 8 formats starting at $310 per kit. Each batch is independently HPLC-verified at 99.45% purity by Janoshik Analytical, with the certificate of analysis published on the lab-results page and matched to the lot number printed on the vial.

Third-party verified batch

Compound	Retatrutide
Research category	Weight Loss
Available formats	5mg10vials, 10mg10vials, 15mg10vials, 20mg10vials, 30mg10vials, 40mg10vials, 50mg10vials, 60mg10vials
Starting price	From $310 USD per kit
Purity	99.45% verified (third-party HPLC, Janoshik)
Test method	HPLC / ESI-MS
Certificate of analysis	Published online, matched to the vial lot number
Intended use	Laboratory research use only. Not for human consumption.
Handling	Supplied lyophilized, store per the stability guide

What Researchers Say

Dr. Vikram Singh

Netherlands

"Our endocrinology research lab at an institutional research lab in London has been using Retatrutide for 9 months for triple receptor metabolic studies. This is genuinely revolutionary - the GLP-1/GIP/Glucagon combination provides insights impossible with semaglutide or tirzepatide alone. We've confirmed all three receptor activation profiles via independent bioassays. Purity consistently >98.5%. Absolutely essential for any serious incretin research program!"

2025-11-13

Research supply buyer

United States

"Held up under our own testing. Keeping them in rotation."

2025-11-11

Aisha M.

Sweden

"Discreet shipping, accurate specs, easy to verify the batch. Solid."

2025-11-09

About This Product

Retatrutide Research Guide

What Makes Retatrutide Different

Retatrutide, developed as Eli Lilly's investigational compound LY3437943, is the first balanced triple agonist in the incretin class. Where Semaglutide engages a single receptor and Tirzepatide engages two, Retatrutide activates three simultaneously: GLP-1, GIP, and glucagon. That third receptor is what moved the field into new territory, because it pulls the energy expenditure lever rather than only the energy intake lever.

The Triple Receptor Mechanism

GLP-1 Receptor: drives glucose-dependent insulin secretion, suppresses glucagon release from pancreatic alpha cells, slows gastric emptying, and acts on hypothalamic appetite centers
GIP Receptor: amplifies the insulin response synergistically with GLP-1 activation, improves lipid handling, and buffers the nausea that caps dose escalation on pure GLP-1 compounds
Glucagon Receptor: increases resting metabolic rate, drives hepatic fat oxidation, and mobilizes fatty acids from adipose tissue

Research Applications

Metabolic pathway studies investigating combined incretin and glucagon signaling
Hepatic fat reduction research where the glucagon component produces the strongest early trial signal
Energy expenditure and thermogenesis models in research cohorts
Comparative research against Semaglutide and Tirzepatide reference baselines
Triple-receptor pharmacology and balanced-agonism characterization

Quality Standards

Purity: 99 percent plus verified by independent third-party HPLC (Janoshik Analytical)
Mass Spec Confirmation: within tolerance of theoretical molecular weight 4731.5 Da
Form: lyophilized powder in sterile vials
Storage: refrigerator for near-term use, minus 20 degrees Celsius long-term
Documentation: batch-matched Certificate of Analysis published at /lab-results, tied to the lot number printed on your vial

For the full mechanism breakdown see the [Retatrutide Triple Agonist Research Guide](/blog/retatrutide-triple-agonist-research-guide). For the head-to-head against the dual and single agonist alternatives, see [Retatrutide vs Tirzepatide vs Semaglutide](/blog/retatrutide-vs-tirzepatide-vs-semaglutide).

For research purposes only. Not for human consumption or therapeutic use.

Research Context for Retatrutide

Metabolic and Weight Loss Research Context

This compound sits in the incretin and metabolic peptide class, where research focuses on appetite regulation, glucose handling, energy expenditure, and the complex signaling network that connects gut, pancreas, liver, and hypothalamus. Research protocols in this category typically involve dose escalation, tolerability mapping, and long-duration observation of metabolic endpoints.

Retatrutide ships as a lyophilized research reagent through the LyzeLabs™ catalog in the Weight Loss category, with 8 variant options sized to different research protocols. Every batch is independently verified by Janoshik Analytical, with the full HPLC chromatogram and mass spectrometry confirmation published on the LyzeLabs lab results page and matched to the lot number printed on your vial.

Related Research Guides

Retatrutide vs Tirzepatide vs Semaglutide

Full receptor-level comparison of the three leading metabolic peptides with a decision framework for research protocols.

Retatrutide Triple Agonist Research Guide

How the GLP-1, GIP, and glucagon receptors combine in one molecule and what that means for metabolic research.

How to Read a Peptide Certificate of Analysis

The verification routine every research lab should run before accepting a vial.

Other Compounds in the Weight Loss Category

Research Tools for This Compound

Frequently Asked Questions

Retatrutide

$310